Cerity Partners’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-15,154
Closed -$942K – 3319
2025
Q4
$942K Buy
15,154
+2,897
+24% +$179K ﹤0.01% 1749
2025
Q3
$736K Sell
12,257
-9,663
-44% -$591K ﹤0.01% 1751
2025
Q2
$1.37M Sell
21,920
-9,164
-29% -$551K ﹤0.01% 1376
2025
Q1
$1.87M Sell
31,084
-19,568
-39% -$1.22M ﹤0.01% 1163
2024
Q4
$2.96M Buy
50,652
+299
+0.6% +$17.8K 0.01% 936
2024
Q3
$2.98M Sell
50,353
-1,139
-2% -$65K 0.01% 913
2024
Q2
$2.89M Sell
51,492
-1,321
-3% -$73.9K 0.01% 773
2024
Q1
$2.94M Buy
52,813
+2,529
+5% +$143K 0.01% 820
2023
Q4
$2.71M Buy
50,284
+5,559
+12% +$272K 0.01% 677
2023
Q3
$2.17M Sell
44,725
-7,341
-14% -$390K 0.01% 570
2023
Q2
$2.94M Buy
52,066
+949
+2% +$52.3K 0.01% 628
2023
Q1
$27.3M Buy
51,117
+42,139
+469% +$2.24M 0.06% 203
2022
Q4
$472K Buy
+8,978
New +$456K ﹤0.01% 967

Other funds holding IHI

Cerity Partners's IHI Position: Q1 2026 in Review

Cerity Partners sold out of iShares US Medical Devices ETF (IHI) in Q1 2026, closing a stake of 15,154 shares — an estimated $942K sold.

Cerity Partners first reported a position in IHI in Q4 2022 and held it in 13 quarters. The position peaked at $27.3M in Q1 2023. 512 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

  • Cerity Partners reported no remaining iShares US Medical Devices ETF position as of Q1 2026 after selling out during the quarter.
  • Cerity Partners sold 15,154 iShares US Medical Devices ETF shares in Q1 2026, an estimated $942K.
  • Cerity Partners first reported a position in iShares US Medical Devices ETF in Q4 2022 and held it in 13 quarters.
  • Cerity Partners's iShares US Medical Devices ETF position peaked at $27.3M in Q1 2023.
  • 512 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.